| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |